查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
2014979

医药物流市场：按类型、产品类型、组件、运输方式和最终用户划分－2026-2032年全球市场预测

Pharmaceutical Logistics Market by Type, Product, Component, Mode Of Transport, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025年医药物流市场价值为900.6亿美元，预计到2026年将成长至966.7亿美元，复合年增长率为8.97%，到2032年将达到1644亿美元。

主要市场统计数据
基准年 2025 900.6亿美元
预计年份：2026年 966.7亿美元
预测年份 2032 1644亿美元
复合年增长率 (%) 8.97%

权威的药品物流指南，揭示了建立具有韧性的供应链所面临的营运压力、合规要求和投资重点。

医药物流产业在临床紧迫性、监管严格性和全球贸易复杂性的交织下运作。近年来，医药供应链面临间歇性中断、不断变化的温控要求以及监管机构和支付方日益严格的审查等挑战。因此，物流相关人员平衡各种相互衝突的需求：既要透过确保产品完整性来保障病人安全，也要同时在高度受限的营运环境中优化成本和前置作业时间。

技术进步、产品复杂性增加以及策略整合如何迅速将医药物流转变为值得信赖的、数据主导的服务经济。

在技​​术成熟、产品特性不断演变以及监管要求日益提高的推动下，医药物流格局正经历着一场变革。复杂生物製药和个人化疗法的出现，促使人们对贯穿整个分销生命週期的精准温控和序列化追踪的需求不断增长，加速了低温运输的专业化和先进监控解决方案的普及应用。同时，能够实现即时视觉化和预测分析的数位化平台，正将价值创造的重心从单纯的运输能力转移到服务品质和可靠性。

2025 年美国关税政策对全球供应链中药品运输路线、供应商选择和贸易合规策略的实际影响。

2025年美国关税环境将对医药物流决策产生复杂影响，迫使企业重新评估全球供应链的运输路线、采购方式和成本分配。关税政策的变化迫使相关人员重新评估供应商和承运商的选择，以降低到货成本波动并维持供应的连续性。对许多生命科学公司而言，目前的因应措施主要集中在战术性：具体而言，包括改变运输路线以避开高关税地区、增加对保税仓库的依赖，以及尽可能加快在地采购，以降低对关税敏感的物流环节的影响。

可操作的细分情报，区分低温运输和非低温运输需求、组件功能、产品复杂性、运输方式、细分应用和最终用户期望。

对市场区隔进行详细分析后发现，不同的需求和服务期望应指南策略投资。就物流类型而言，低温运输物流需要端到端的温度控制、严格的保温包装认证以及​​支援监管可追溯性的监控技术。而非低温运输物流则更注重货量、运输效率和成本最佳化的仓储策略。这两种物流类型之间的转换需要清晰的营运规程和资金配置决策。

从区域观点看美洲、欧洲、中东和非洲以及亚太地区的医药物流基础设施、监管细微差别和营运重点。

区域趋势影响物流供应商和製药公司的营运重点和投资决策。在美洲，重点在于分销规模和最后一公里优化，特别关注北美地区的跨境物流流动以及拉丁美洲市场基础设施​​的多样性。应对这些挑战需要高度灵活的运输策略、完善的清关流程以及能够确保跨区域低温运输稳定运作的伙伴关係。

决定医药分销领域物流供应商和技术供应商成功的关键竞争差异化因素和伙伴关係策略。

物流和服务供应商之间的竞争格局正趋于几个关键差异化因素：成熟的低温运输专业知识、数位化视觉性和分析能力、合规性和品管，以及覆盖范围广且具备专业优势的细分市场。领先的供应商正在投资建造检验的仓储设施、整合监控系统以及能够支援对温度敏感的生物製药和大批量药品分销的服务组合。透过这些倡议，他们正从单纯的承运商转型为承担端到端责任的整合供应链合作伙伴。

为产业领导者提供切实可行的多面向蓝图，以推动营运课责，同时加强低温运输韧性、贸易弹性和策略伙伴关係。

产业领导者必须采取综合策略，兼顾短期韧性与长期转型。首先，投资建设分层式低温运输基础设施，使设施认证和温度控制技术与产品风险等级相符。这种方法能够将高成本的资源有效率地分配给对温度最敏感的SKU，同时保持柔软性，满足各种不同的配送需求。为了配合实体投资，还应实施先进的监控和分析技术，从被动的事件管理转向预测性维护和路线最佳化。

透过基于从业者观点的高度透明的调查方法，我们将对高阶主管的初步访谈与辅助性二手资讯结合，从而得出有关物流的实用见解。

本分析整合了第一手和第二手调查数据，旨在对医药物流趋势进行严谨且可重复的评估。第一手调查包括对製造和医疗机构的高级物流主管、低温运输专家、法规遵循官员和采购负责人进行结构化访谈。访谈内容聚焦于营运重点、能力差距、技术应用以及对贸易和政策变化的因应观点，从而提供切实可行的建议。

结论阐述了为什么对低温运输能力、数位化可视性和管治的策略性投资正在决定医药供应链的领导地位。

高效率的医药物流不再只是后勤部门职能，而是提升竞争力的关键驱动力，随着产品复杂性和监管要求的提高，其重要性只会与日俱增。那些将物流视为战略能力，并将对检验的低温运输基础设施、先进的监测分析技术以及贸易和政策适应能力的投资纳入其计划的企业，将更有能力确保产品完整性，满足患者需求，并有效控制服务总成本。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 市场进入策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 医药物流市场：依类型划分

  • 低温运输物流
  • 非低温运输物流

第九章 医药物流市场：依产品划分

  • 生物製药
    • 单株抗体
    • 胜肽
    • 蛋白质
  • 品牌药品
  • 学名药
    • 非处方药（OTC）
    • 处方笺学名药

第十章 医药物流市场：依组成部分划分

  • 分配
  • 监测
  • 包装
  • 仓储管理

第十一章 以运输方式分類的医药物流市场

  • 空运货物
    • 包机
    • 普通货物
  • 陆路交通
    • 铁路
    • 卡车运输
  • 海上运输
    • 货柜运输
    • 滚装船

第十二章 医药物流市场：依最终用户划分

  • 医疗保健提供者
  • 製药生产
  • 研究机构

第十三章 医药物流市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 医药物流市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 医药物流市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国医学流市场

第十七章：中国医药药物流市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • AP Moller-Maersk A/S
  • Air Canada
  • AIT Worldwide Logistics, Inc.
  • Almac Group
  • AWL India Private Limited
  • Bilcare Limited
  • CH Robinson Worldwide, Inc.
  • Catalent, Inc.
  • Cencora Inc.
  • CEVA Logistics
  • Clinigen Group PLC
  • Crown LSP Group
  • DHL International GmbH by Deutsche Post AG
  • DSV A/S
  • FedEx Corporation
  • ICON PLC
  • Infosys Limited
  • Kerry Logistics Network Limited
  • Kuehne+Nagel International AG
  • Lineage, Inc.
  • Lonza Group Ltd.
  • Movianto Group
  • NextPharma Logistics GmbH
  • Nippon Express Co., Ltd.
  • Parexel International Corporation
  • SEKO Logistics
  • SF Express Co., Ltd.
  • Thermo Fisher Scientific, Inc.
  • United Parcel Service of America, Inc.
  • YUSEN LOGISTICS CO., LTD.
Product Code: MRR-437E8FA7421A

The Pharmaceutical Logistics Market was valued at USD 90.06 billion in 2025 and is projected to grow to USD 96.67 billion in 2026, with a CAGR of 8.97%, reaching USD 164.40 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 90.06 billion
Estimated Year [2026] USD 96.67 billion
Forecast Year [2032] USD 164.40 billion
CAGR (%) 8.97%

An authoritative orientation to pharmaceutical logistics that clarifies operational pressures, compliance imperatives, and investment priorities shaping resilient supply chains

The pharmaceutical logistics sector operates at the confluence of clinical urgency, regulatory rigor, and global trade complexity. In recent years, supply chains for pharmaceuticals have been tested by episodic disruptions, evolving temperature-control demands, and heightened scrutiny from regulators and payors. Consequently, logistics stakeholders must balance competing imperatives: ensuring patient safety through uncompromising product integrity while simultaneously optimizing cost and lead times in a constrained operating environment.

This report presents an integrated vantage that synthesizes operational realities, technology adoption trends, and policy dynamics affecting logistics providers, manufacturers, and institutional buyers. It frames critical vulnerabilities and strengths within distribution networks and underscores the role of collaborative partnerships in maintaining continuity. By assessing the interplay between infrastructure capabilities, service design, and compliance obligations, the analysis helps leaders prioritize investments that reduce risk and increase responsiveness.

Throughout the review, emphasis is placed on the practical implications of emerging practices such as advanced temperature monitoring, end-to-end visibility platforms, and modular warehousing strategies. These elements are examined not only for their technological sophistication but also for their operational feasibility, cost-to-implement considerations, and alignment with stakeholder expectations across clinical, commercial, and regulatory functions.

How technological advances, product complexity, and strategic consolidation are rapidly reshaping pharmaceutical logistics into a reliability- and data-driven service economy

The landscape of pharmaceutical logistics is undergoing transformative shifts driven by technological maturation, changing product profiles, and intensified regulatory expectations. Complex biologic products and personalized therapies have increased demand for precise temperature controls and serialized tracking throughout the distribution lifecycle, which in turn accelerates adoption of cold chain specialization and advanced monitoring solutions. Simultaneously, digital platforms enabling real-time visibility and predictive analytics are shifting value capture from capacity alone toward service quality and reliability.

In parallel, the industry is witnessing consolidation among third-party logistics providers and strategic alliances between carriers and life sciences companies, which reconfigure network design and service offerings. These structural changes are reinforced by investments in flexible storage and packaging systems that support multi-temperature SKUs and rapid fulfillment for time-sensitive deliveries. Moreover, environmental sustainability considerations are prompting experimentation with reusable packaging and energy-efficient cold storage, adding another layer of decision criteria for operators.

Taken together, these developments demand a reorientation of capabilities. Providers that integrate robust monitoring, adaptable storage, and agile transport orchestration position themselves to meet evolving product complexity and heightened customer expectations. At the same time, manufacturers and institutional buyers are recalibrating supplier selection criteria to emphasize reliability, data transparency, and proven cold chain expertise, creating a new competitive dynamic in logistics procurement.

Practical implications of the 2025 United States tariff policy on pharmaceutical routing, supplier selection, and trade-compliance strategies across global supply chains

The United States tariff environment in 2025 has created a complex overlay on pharmaceutical logistics decisions, reshaping routing, sourcing, and cost allocation across global supply chains. Tariff policy changes have prompted stakeholders to reassess supplier and carrier selection in order to mitigate landed-cost volatility and maintain supply continuity. For many life sciences organizations, the immediate response has been tactical: rerouting shipments to avoid high-duty corridors, increasing reliance on bonded warehousing, and accelerating localization where feasible to reduce exposure to tariff-sensitive flows.

Beyond those immediate adjustments, the tariff landscape is also catalyzing strategic shifts. Firms are reassessing regional network design to diversify inbound flows across ports and transport modes, and are renegotiating commercial terms with logistics partners to share or hedge tariff risk. In addition, companies are placing greater emphasis on documentation integrity and customs compliance capabilities to minimize costly delays and penalties that can compound the financial impact of duties. These changes have secondary effects on inventory policy, with some organizations opting to increase safety stock in proximate distribution centers to offset potential border disruptions.

Ultimately, the tariff-driven reconfiguration highlights the importance of agility and scenario planning in logistics strategy. Organizations that proactively incorporate trade-policy sensitivity into routing algorithms, supplier contracts, and inventory positioning will be better equipped to preserve service levels while managing cost exposure in an uncertain trade environment.

Actionable segmentation intelligence that differentiates cold chain and non-cold chain needs, component capabilities, product complexity, transport modes, application niches, and end-user expectations

A granular view of segmentation reveals differentiated needs and service expectations that should guide strategic investments. When considering logistical type, cold chain logistics demands end-to-end temperature integrity, rigorous qualification of insulated packaging, and monitoring technologies that support regulatory traceability, whereas non-cold chain logistics emphasizes volume handling, transit efficiency, and cost-optimized storage strategies. Transitioning between these types requires distinct operational protocols and capital allocation decisions.

Component-level segmentation further clarifies capability gaps and procurement priorities. Distribution operations call for flexible transportation modes and reliable carrier networks; monitoring necessitates investment in sensors, data platforms, and analytics to evidence compliance; packaging solutions must balance thermal performance with material sustainability; and storage and warehousing require facility qualification, validated temperature zones, and trained personnel to manage sensitive inventory.

Product-driven segmentation underpins service differentiation. Biologic products, including monoclonal antibodies, peptides, and proteins, typically require stringent cold chain controls and traceable handling, while branded drugs often combine temperature requirements with commercial distribution rules. Generic pharmaceuticals split into over-the-counter and prescription generics, each presenting different demand patterns and packaging resilience, which influence choices in transport frequency, containerization, and inventory tactics.

Mode of transport segmentation influences speed, cost, and risk profiles. Air freight, whether via charter services or commercial cargo, prioritizes speed and minimal dwell time; road transportation-across rail and trucking-offers cost-efficient regional connectivity and flexibility for last-mile delivery; and sea freight through container shipping or roll-on/roll-off presents economies for bulk international movements but introduces longer lead times and greater exposure to temperature excursions.

Application-based segmentation highlights sector-specific workflows. Bio pharma requires stringent compliance protocols and often cold chain specialization, chemical pharma demands hazardous-material handling expertise and controlled environments, and specialized pharma may combine unique handling, security, and documentation needs. Finally, end-user segmentation into healthcare providers, pharmaceutical manufacturing, and research institutions shapes service level agreements, delivery cadence, and value-added services such as direct-to-clinic fulfillment or clinical trial kit management.

A region-by-region perspective on infrastructure, regulatory nuance, and operational priorities shaping pharmaceutical logistics in the Americas, EMEA, and Asia-Pacific

Regional dynamics shape operational priorities and investment decisions for logistics providers and pharmaceutical companies. In the Americas, emphasis is placed on distribution scale and last-mile optimization, with particular attention to cross-border flows in North America and to infrastructure variability across Latin American markets. These conditions require adaptable transport strategies, enhanced customs proficiency, and partnerships that can deliver consistent cold chain performance across diverse geographies.

In Europe, Middle East & Africa, regulatory harmonization in parts of Europe intersects with fragmented infrastructure in other areas, creating a mosaic of compliance and operational requirements. Providers must balance centralized distribution models that leverage advanced hub capabilities with localized solutions that handle last-mile complexity and country-specific regulations. The region also presents opportunities to deploy energy-efficient cold storage solutions and integrated visibility platforms to manage cross-border cold chain integrity.

Asia-Pacific continues to be characterized by rapidly evolving manufacturing footprints, urbanization-driven last-mile challenges, and a broad spectrum of infrastructure maturity. Many markets within the region are scaling up biologics manufacturing capacity and demand sophisticated cold chain capabilities, prompting investments in qualified warehousing and multimodal transport options. Across regions, stakeholders increasingly prioritize partnerships that combine local market expertise with global standards to manage compliance, security, and service reliability.

Key competitive differentiators and partnership strategies that are defining success among logistics providers and technology suppliers in pharmaceutical distribution

Competitive dynamics among logistics and service providers are converging on a few decisive differentiators: proven cold chain expertise, digital visibility and analytics, compliance and quality management, and geographic reach combined with niche specialization. Leading providers are investing in validated storage facilities, integrated monitoring systems, and service portfolios that support temperature-sensitive biologics alongside high-volume pharmaceutical distribution. In doing so, they are repositioning from pure-transport businesses toward integrated supply chain partners that offer end-to-end accountability.

Strategic partnerships and acquisitions are being used to accelerate capability development, especially where rapid entry into specialized cold chain services or regional markets is required. Technology vendors that supply monitoring hardware and software platforms are increasingly collaborating with logistics providers to embed continuous temperature sensing, automated alerts, and data analytics into routine operations. This integration enhances compliance documentation, reduces manual processes, and supports performance-based commercial models.

From a buyer perspective, supplier selection criteria have shifted to emphasize transparency, incident response capability, and auditable processes. Organizations are also evaluating providers on their ability to support circular packaging initiatives and sustainability commitments without compromising cold chain integrity. As a result, providers that can demonstrate measurable improvements in service reliability, robust quality systems, and a clear roadmap for innovation are most likely to capture strategic engagements.

A pragmatic, multi-dimensional roadmap for industry leaders to strengthen cold chain resilience, trade agility, and strategic partnerships while driving operational accountability

Industry leaders must adopt an integrated agenda that balances immediate resilience with longer-term transformation. First, invest in tiered cold chain infrastructure that aligns facility qualification and temperature-control technology to product risk profiles. This approach enables efficient allocation of high-cost resources to the most temperature-sensitive SKUs while preserving flexibility for broader distribution needs. Complementary to physical investments, deploy advanced monitoring and analytics to move from reactive incident management toward predictive maintenance and route optimization.

Second, embed trade-policy and customs expertise into supply chain planning to mitigate tariff and regulatory volatility. Scenario-based modeling and dynamic routing protocols can reduce exposure to sudden policy shifts, while stronger contractual terms with carriers can share risk in high-exposure corridors. Third, prioritize partnerships with specialized providers and technology vendors to accelerate capability expansion; strategic alliances can deliver validated cold storage, last-mile expertise, and integrated data platforms without requiring full in-house development.

Finally, build governance and performance frameworks that align procurement, quality, and operations. Instituting clear service-level agreements, incident response playbooks, and continuous improvement cycles ensures accountability and drives measurable reliability gains. By pursuing this multi-pronged strategy, leaders can reduce service disruption risk, control costs pragmatically, and strengthen their ability to support increasingly complex pharmaceutical product portfolios.

A transparent, practitioner-focused research methodology integrating primary leadership interviews and corroborating secondary sources to produce actionable logistics insights

This analysis synthesizes primary and secondary research to produce a rigorous, reproducible assessment of pharmaceutical logistics dynamics. Primary research included structured interviews with senior logistics executives, cold chain specialists, regulatory compliance leads, and procurement professionals across manufacturing and healthcare organizations. These conversations focused on operational priorities, capability gaps, technology adoption, and responses to trade and policy shifts, providing frontline perspectives that inform practical recommendations.

Secondary research comprised a review of publicly available regulatory guidance, industry white papers, technology provider specification documents, and case studies from leading logistics implementations. Triangulation of primary insights with secondary evidence allowed for validation of emergent themes such as the increased focus on biologics cold chain, the centrality of digital visibility, and the operational consequences of tariff shifts. Methodological rigor was maintained through cross-validation among interviewees, iterative synthesis of common patterns, and attention to regional differentiators that affect feasibility and prioritization.

Limitations are acknowledged: the analysis focuses on structural and operational trends rather than quantitative market sizing, and while it accounts for a broad set of geographies and stakeholder types, some micro-market nuances may require localized validation. Nonetheless, the methodology emphasizes applicability, ensuring that findings support actionable decisions for procurement, operations, and strategic planning.

Concluding perspective on why strategic investment in cold chain capabilities, digital visibility, and governance will determine pharmaceutical supply chain leadership

Effective pharmaceutical logistics is now a competitive enabler rather than a back-office function, and its importance will only increase as product complexity and regulatory expectations rise. Organizations that treat logistics as a strategic capability-investing in validated cold chain infrastructure, integrating advanced monitoring and analytics, and embedding trade-policy resilience into planning-will be better positioned to ensure product integrity, meet patient needs, and manage total cost to serve.

Moreover, the convergence of technology and specialized service models creates an opportunity to shift provider relationships from transactional to strategic partnerships. By prioritizing transparency, data-driven decision-making, and continuous improvement, stakeholders can reduce supply disruptions and create operational agility. As the industry adapts to tariff dynamics, evolving product profiles, and regional infrastructure variances, the capacity to translate insight into nimble execution will distinguish leaders from laggards.

In closing, the imperative is clear: align investments to product risk, leverage partnerships to accelerate capability, and institutionalize governance that converts operational improvements into reliable, auditable performance. Doing so will enable sustainable, resilient pharmaceutical logistics that uphold patient safety and commercial continuity.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Pharmaceutical Logistics Market, by Type

  • 8.1. Cold Chain Logistics
  • 8.2. Non-Cold Chain Logistics

9. Pharmaceutical Logistics Market, by Product

  • 9.1. Biologic Products
    • 9.1.1. Monoclonal Antibodies
    • 9.1.2. Peptides
    • 9.1.3. Proteins
  • 9.2. Branded Drugs
  • 9.3. Generic Pharmaceuticals
    • 9.3.1. Over-The-Counter (OTC)
    • 9.3.2. Prescription Generics

10. Pharmaceutical Logistics Market, by Component

  • 10.1. Distribution
  • 10.2. Monitoring
  • 10.3. Packaging
  • 10.4. Storage & Warehousing

11. Pharmaceutical Logistics Market, by Mode Of Transport

  • 11.1. Air Freight
    • 11.1.1. Charter Services
    • 11.1.2. Commercial Cargo
  • 11.2. Road Transportation
    • 11.2.1. Rail
    • 11.2.2. Trucking
  • 11.3. Sea Freight
    • 11.3.1. Container Shipping
    • 11.3.2. Roll-On/Roll-Off

12. Pharmaceutical Logistics Market, by End User

  • 12.1. Healthcare Providers
  • 12.2. Pharmaceutical Manufacturing
  • 12.3. Research Institutions

13. Pharmaceutical Logistics Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Pharmaceutical Logistics Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Pharmaceutical Logistics Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Pharmaceutical Logistics Market

17. China Pharmaceutical Logistics Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. A.P. Moller - Maersk A/S
  • 18.6. Air Canada
  • 18.7. AIT Worldwide Logistics, Inc.
  • 18.8. Almac Group
  • 18.9. AWL India Private Limited
  • 18.10. Bilcare Limited
  • 18.11. C.H. Robinson Worldwide, Inc.
  • 18.12. Catalent, Inc.
  • 18.13. Cencora Inc.
  • 18.14. CEVA Logistics
  • 18.15. Clinigen Group PLC
  • 18.16. Crown LSP Group
  • 18.17. DHL International GmbH by Deutsche Post AG
  • 18.18. DSV A/S
  • 18.19. FedEx Corporation
  • 18.20. ICON PLC
  • 18.21. Infosys Limited
  • 18.22. Kerry Logistics Network Limited
  • 18.23. Kuehne + Nagel International AG
  • 18.24. Lineage, Inc.
  • 18.25. Lonza Group Ltd.
  • 18.26. Movianto Group
  • 18.27. NextPharma Logistics GmbH
  • 18.28. Nippon Express Co., Ltd.
  • 18.29. Parexel International Corporation
  • 18.30. SEKO Logistics
  • 18.31. SF Express Co., Ltd.
  • 18.32. Thermo Fisher Scientific, Inc.
  • 18.33. United Parcel Service of America, Inc.
  • 18.34. YUSEN LOGISTICS CO., LTD.

LIST OF FIGURES

  • FIGURE 1. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PHARMACEUTICAL LOGISTICS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COLD CHAIN LOGISTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COLD CHAIN LOGISTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COLD CHAIN LOGISTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY NON-COLD CHAIN LOGISTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY NON-COLD CHAIN LOGISTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY NON-COLD CHAIN LOGISTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BIOLOGIC PRODUCTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BIOLOGIC PRODUCTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BIOLOGIC PRODUCTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BIOLOGIC PRODUCTS, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PEPTIDES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PEPTIDES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PEPTIDES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PROTEINS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PROTEINS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PROTEINS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BRANDED DRUGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BRANDED DRUGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BRANDED DRUGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GENERIC PHARMACEUTICALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GENERIC PHARMACEUTICALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GENERIC PHARMACEUTICALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GENERIC PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OVER-THE-COUNTER (OTC), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OVER-THE-COUNTER (OTC), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OVER-THE-COUNTER (OTC), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRESCRIPTION GENERICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRESCRIPTION GENERICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRESCRIPTION GENERICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY DISTRIBUTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY DISTRIBUTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY DISTRIBUTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PACKAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PACKAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PACKAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY STORAGE & WAREHOUSING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY STORAGE & WAREHOUSING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY STORAGE & WAREHOUSING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY AIR FREIGHT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY AIR FREIGHT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY AIR FREIGHT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY AIR FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY CHARTER SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY CHARTER SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY CHARTER SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COMMERCIAL CARGO, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COMMERCIAL CARGO, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COMMERCIAL CARGO, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY ROAD TRANSPORTATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY ROAD TRANSPORTATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY ROAD TRANSPORTATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY ROAD TRANSPORTATION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY RAIL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY RAIL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY RAIL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRUCKING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRUCKING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TRUCKING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SEA FREIGHT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SEA FREIGHT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SEA FREIGHT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SEA FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY CONTAINER SHIPPING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY CONTAINER SHIPPING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY CONTAINER SHIPPING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY ROLL-ON/ROLL-OFF, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY ROLL-ON/ROLL-OFF, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY ROLL-ON/ROLL-OFF, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY HEALTHCARE PROVIDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY HEALTHCARE PROVIDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY HEALTHCARE PROVIDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY RESEARCH INSTITUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY RESEARCH INSTITUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BIOLOGIC PRODUCTS, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GENERIC PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS PHARMACEUTICAL LOGISTICS MARKET SIZE, BY AIR FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS PHARMACEUTICAL LOGISTICS MARKET SIZE, BY ROAD TRANSPORTATION, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SEA FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BIOLOGIC PRODUCTS, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GENERIC PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY AIR FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY ROAD TRANSPORTATION, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SEA FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BIOLOGIC PRODUCTS, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GENERIC PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY AIR FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY ROAD TRANSPORTATION, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SEA FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BIOLOGIC PRODUCTS, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GENERIC PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY AIR FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY ROAD TRANSPORTATION, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SEA FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BIOLOGIC PRODUCTS, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GENERIC PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE PHARMACEUTICAL LOGISTICS MARKET SIZE, BY AIR FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE PHARMACEUTICAL LOGISTICS MARKET SIZE, BY ROAD TRANSPORTATION, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SEA FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BIOLOGIC PRODUCTS, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GENERIC PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST PHARMACEUTICAL LOGISTICS MARKET SIZE, BY AIR FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 154. MIDDLE EAST PHARMACEUTICAL LOGISTICS MARKET SIZE, BY ROAD TRANSPORTATION, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SEA FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 156. MIDDLE EAST PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BIOLOGIC PRODUCTS, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GENERIC PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 162. AFRICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 163. AFRICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 164. AFRICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY AIR FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 165. AFRICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY ROAD TRANSPORTATION, 2018-2032 (USD MILLION)
  • TABLE 166. AFRICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SEA FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 167. AFRICA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BIOLOGIC PRODUCTS, 2018-2032 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GENERIC PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 173. ASIA-PACIFIC PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 174. ASIA-PACIFIC PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC PHARMACEUTICAL LOGISTICS MARKET SIZE, BY AIR FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 176. ASIA-PACIFIC PHARMACEUTICAL LOGISTICS MARKET SIZE, BY ROAD TRANSPORTATION, 2018-2032 (USD MILLION)
  • TABLE 177. ASIA-PACIFIC PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SEA FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 178. ASIA-PACIFIC PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 180. ASEAN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. ASEAN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. ASEAN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 183. ASEAN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BIOLOGIC PRODUCTS, 2018-2032 (USD MILLION)
  • TABLE 184. ASEAN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GENERIC PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 185. ASEAN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 186. ASEAN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 187. ASEAN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY AIR FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 188. ASEAN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY ROAD TRANSPORTATION, 2018-2032 (USD MILLION)
  • TABLE 189. ASEAN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SEA FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 190. ASEAN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 191. GCC PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 192. GCC PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. GCC PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 194. GCC PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BIOLOGIC PRODUCTS, 2018-2032 (USD MILLION)
  • TABLE 195. GCC PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GENERIC PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 196. GCC PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 197. GCC PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 198. GCC PHARMACEUTICAL LOGISTICS MARKET SIZE, BY AIR FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 199. GCC PHARMACEUTICAL LOGISTICS MARKET SIZE, BY ROAD TRANSPORTATION, 2018-2032 (USD MILLION)
  • TABLE 200. GCC PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SEA FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 201. GCC PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPEAN UNION PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPEAN UNION PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPEAN UNION PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPEAN UNION PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BIOLOGIC PRODUCTS, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPEAN UNION PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GENERIC PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPEAN UNION PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPEAN UNION PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPEAN UNION PHARMACEUTICAL LOGISTICS MARKET SIZE, BY AIR FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPEAN UNION PHARMACEUTICAL LOGISTICS MARKET SIZE, BY ROAD TRANSPORTATION, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPEAN UNION PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SEA FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPEAN UNION PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 213. BRICS PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 214. BRICS PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. BRICS PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 216. BRICS PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BIOLOGIC PRODUCTS, 2018-2032 (USD MILLION)
  • TABLE 217. BRICS PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GENERIC PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 218. BRICS PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 219. BRICS PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 220. BRICS PHARMACEUTICAL LOGISTICS MARKET SIZE, BY AIR FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 221. BRICS PHARMACEUTICAL LOGISTICS MARKET SIZE, BY ROAD TRANSPORTATION, 2018-2032 (USD MILLION)
  • TABLE 222. BRICS PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SEA FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 223. BRICS PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 224. G7 PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 225. G7 PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 226. G7 PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 227. G7 PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BIOLOGIC PRODUCTS, 2018-2032 (USD MILLION)
  • TABLE 228. G7 PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GENERIC PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 229. G7 PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 230. G7 PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 231. G7 PHARMACEUTICAL LOGISTICS MARKET SIZE, BY AIR FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 232. G7 PHARMACEUTICAL LOGISTICS MARKET SIZE, BY ROAD TRANSPORTATION, 2018-2032 (USD MILLION)
  • TABLE 233. G7 PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SEA FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 234. G7 PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 235. NATO PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 236. NATO PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 237. NATO PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 238. NATO PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BIOLOGIC PRODUCTS, 2018-2032 (USD MILLION)
  • TABLE 239. NATO PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GENERIC PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 240. NATO PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 241. NATO PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 242. NATO PHARMACEUTICAL LOGISTICS MARKET SIZE, BY AIR FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 243. NATO PHARMACEUTICAL LOGISTICS MARKET SIZE, BY ROAD TRANSPORTATION, 2018-2032 (USD MILLION)
  • TABLE 244. NATO PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SEA FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 245. NATO PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 246. GLOBAL PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 247. UNITED STATES PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 248. UNITED STATES PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 249. UNITED STATES PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 250. UNITED STATES PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BIOLOGIC PRODUCTS, 2018-2032 (USD MILLION)
  • TABLE 251. UNITED STATES PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GENERIC PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 252. UNITED STATES PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 253. UNITED STATES PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 254. UNITED STATES PHARMACEUTICAL LOGISTICS MARKET SIZE, BY AIR FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 255. UNITED STATES PHARMACEUTICAL LOGISTICS MARKET SIZE, BY ROAD TRANSPORTATION, 2018-2032 (USD MILLION)
  • TABLE 256. UNITED STATES PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SEA FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 257. UNITED STATES PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 258. CHINA PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 259. CHINA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 260. CHINA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 261. CHINA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BIOLOGIC PRODUCTS, 2018-2032 (USD MILLION)
  • TABLE 262. CHINA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GENERIC PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 263. CHINA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 264. CHINA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY MODE OF TRANSPORT, 2018-2032 (USD MILLION)
  • TABLE 265. CHINA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY AIR FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 266. CHINA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY ROAD TRANSPORTATION, 2018-2032 (USD MILLION)
  • TABLE 267. CHINA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SEA FREIGHT, 2018-2032 (USD MILLION)
  • TABLE 268. CHINA PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)